We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.56%
4 Consumer Discretionary 5.98%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
1451
Goldman Sachs
GS
$303B
$425K ﹤0.01%
484
-2,480
-84% -$2.02M
WTS icon
1452
Watts Water Technologies
WTS
$13.1B
$425K ﹤0.01%
1,539
-5,155
-77% -$1.42M
CIM
1453
Chimera Investment
CIM
$1B
$424K ﹤0.01%
+34,110
New +$433K
SNDR icon
1454
Schneider National
SNDR
$6.25B
$424K ﹤0.01%
15,980
+5,134
+47% +$121K
MUX icon
1455
McEwen Inc
MUX
$1.18B
$424K ﹤0.01%
+22,881
New +$426K
DHI icon
1456
D.R. Horton
DHI
$42.3B
$422K ﹤0.01%
2,932
+2,908
+12,117% +$443K
UGP icon
1457
Ultrapar
UGP
$6.54B
$422K ﹤0.01%
111,972
+99,672
+810% +$394K
IBM icon
1458
IBM
IBM
$224B
$419K ﹤0.01%
1,416
+678
+92% +$203K
FMNB icon
1459
Farmers National Banc Corp
FMNB
$930M
$418K ﹤0.01%
+31,379
New +$429K
UCB
1460
United Community Banks
UCB
$4.28B
$416K ﹤0.01%
+13,335
New +$412K
PGAC
1461
Pantages Capital Acquisition Corp
PGAC
$415K ﹤0.01%
40,000
-9,662
-19% -$99.7K
SNV
1462
DELISTED
Synovus
SNV
$415K ﹤0.01%
8,290
-55,992
-87% -$2.69M
COLL icon
1463
Collegium Pharmaceutical
COLL
$956M
$414K ﹤0.01%
+8,932
New +$374K
PAM icon
1464
Pampa Energía
PAM
$4.41B
$413K ﹤0.01%
+4,668
New +$376K
EXPO icon
1465
Exponent
EXPO
$3.24B
$412K ﹤0.01%
5,934
-69,364
-92% -$4.87M
GSM icon
1466
FerroAtlántica
GSM
$839M
$409K ﹤0.01%
88,214
+61,405
+229% +$283K
WDFC icon
1467
WD-40
WDFC
$3.15B
$409K ﹤0.01%
2,078
-5,434
-72% -$1.07M
DFTX
1468
Definium Therapeutics
DFTX
$6.12B
$408K ﹤0.01%
30,456
-5,054
-14% -$62.5K
OTGAU
1469
OTG Acquisition Corp I Unit
OTGAU
$408K ﹤0.01%
40,000
-38,843
-49% -$395K
ROL icon
1470
Rollins
ROL
$18.2B
$407K ﹤0.01%
6,784
+867
+15% +$50.9K
CEPV
1471
Cantor Equity Partners V
CEPV
$331M
$404K ﹤0.01%
+39,456
New +$405K
SYF icon
1472
Synchrony
SYF
$25.6B
$401K ﹤0.01%
+4,806
New +$367K
SIFY
1473
Sify Technologies
SIFY
$1.14B
$400K ﹤0.01%
+32,801
New +$400K
LOPE icon
1474
Grand Canyon Education
LOPE
$3.98B
$399K ﹤0.01%
2,400
+807
+51% +$146K
BLCO icon
1475
Bausch + Lomb
BLCO
$5.99B
$397K ﹤0.01%
+23,236
New +$368K

Similar funds

Schonfeld Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Schonfeld Strategic Advisors held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schonfeld Strategic Advisors deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Schonfeld Strategic Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Schonfeld Strategic Advisors fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Schonfeld Strategic Advisors opened 620 new positions and closed 789 in Q4 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.